GRP and chronic kidney disease: Here, we found that the increased expression of GRP and GRP receptor was involved in HP-induced vascular calcification in CKD mice and RC-3095 treatment significantly attenuated the arterial medial calcification in them, making GRP a potential therapeutic target for vascular calcification in CKD.